Skip to main content
Year archive

ALLERGY THERAPEUTICS PLC — 2023 filings

All 42 regulatory filings released by ALLERGY THERAPEUTICS PLC (AGY) in 2023, sourced directly from the official regulator.

42 Filings
2023 Period
2023 filings (42)
Filing Released Lang
Amendment to existing Facility Agreement
Regulatory Filings
2023-12-27 English
Annual Report and Accounts Delayed
Regulatory Filings
2023-12-15 English
PDMR dealing and Total Voting Rights
Director's Dealing
2023-12-13 English
G306 Phase III trial meets key endpoints
Regulatory Filings
2023-12-13 English
Update on funding
Capital/Financing Update
2023-12-11 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-12-01 English
Holding(s) in Company
Major Shareholding Notification
2023-11-28 English
G306 Grass Phase III trial meets primary endpoint
Regulatory Filings
2023-11-14 English
Director/PCA Dealing
Director's Dealing
2023-11-10 English
Holding(s) in Company
Major Shareholding Notification
2023-11-10 English
Exercise of Options and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-11-09 English
Update on funding
Capital/Financing Update
2023-11-06 English
Holding(s) in Company
Major Shareholding Notification
2023-10-20 English
Southern Fox: Form 8.3 – Allergy Therapeutics Plc
Director's Dealing
2023-10-16 English
Holding(s) in Company
Major Shareholding Notification
2023-10-16 English
Result of Open Offer and Subscription
Declaration of Voting Results & Voting Rights Announcements
2023-10-13 English
Block Listing Interim Review
Share Issue/Capital Change
2023-10-02 English
Publication of Open Offer Circular – Amendment
Share Issue/Capital Change
2023-09-27 English
Publication of Open Offer Circular
Share Issue/Capital Change
2023-09-27 English
Unaudited Preliminary Results 2023
Earnings Release FY 2023
2023-09-27 English
Phase I VLP Peanut PROTECT trial progress
Regulatory Filings
2023-09-26 English
Satisfaction of FDI clearance conditions
Share Issue/Capital Change
2023-09-22 English
Trading update for the year ended 30 June 2023
Earnings Release FY 2023
2023-08-10 English
Result of General Meeting
AGM Information
2023-07-31 English
Appointment of Chief Financial Officer
Board/Management Information
2023-07-10 English
Interim Results and Lifting Suspension in Trading
Interim / Quarterly Report H1 2023
2023-06-19 English
Publication of Annual Report and Accounts 2022
Report Publication Announcement
2023-06-19 English
Allergy Therapeutics shares key findings at EAACI
Regulatory Filings
2023-06-09 English
Result of General Meeting
Declaration of Voting Results & Voting Rights Announcements
2023-04-27 English
Southern Fox: Form 8.3 – Allergy Therapeutics Plc
Major Shareholding Notification
2023-04-24 English
FORM 8 (OPD) – Allergy Therapeutics plc
Regulatory Filings
2023-04-21 English
Project Zebra Rule 2.9 Announcement
Declaration of Voting Results & Voting Rights Announcements
2023-04-20 English
Skin-prick testing completes in PROTECT Trial
Regulatory Filings
2023-04-19 English
£40.75 million Facility with Equity Financing
Capital/Financing Update
2023-04-06 English
Trading and Business Update
Regulatory Filings
2023-04-06 English
Publication of Interim Results Delayed
Regulatory Filings
2023-03-29 English
Patients dosed in VLP Peanut PROTECT trial
Regulatory Filings
2023-03-27 English
Block Listing Interim Review
Share Issue/Capital Change
2023-03-08 English
PDMR Dealing
Regulatory Filings
2023-03-03 English
Result of AGM
AGM Information
2023-02-07 English
Half-Year Trading Update 2023
Earnings Release H1 2023
2023-01-20 English
NOTICE OF 2022 ANNUAL GENERAL MEETING
AGM Information
2023-01-13 English